Latest Hematopoietic stem cell transplantation Stories
DUBLIN, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wfh3fh/capitalizing_on) has announced the addition of the "Capitalizing
DUBLIN, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/8pg6t9/capitalizing_on) has announced the addition of the "Capitalizing
Investigators at Johns Hopkins report they have developed human induced-pluripotent stem cells (iPSCs) capable of repairing damaged retinal vascular tissue in mice.
- BL-8040 previously received Orphan Drug Designation for treatment of Acute Myeloid Leukemia - JERUSALEM, Jan.
The "Good Morning America" anchor continues her efforts to recruit volunteer bone marrow donors to the national Be The Match Registry® while stressing the importance of research.
Phase 1 Trial of BL-8040 expected to begin in Q2 2014; top-line results expected in H2 2014 JERUSALEM, Jan.
An exciting breakthrough is offering hope for the treatment of blood diseases such as leukemia using artificial bone marrow.
NEW YORK, Jan. 8, 2014 /PRNewswire/ -- Bone marrow transplants are a $1.3 billion market and the fastest-growing hospital procedure in the U.S.
Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...
- A handkerchief.
- Specifically— The legendary sweat-cloth; the handkerchief of St. Veronica, according to tradition miraculously impressed with the mask of Christ; also, the napkin about Christ's head (Johu xx. 7).
- In general, any miraculous portrait of Christ.